Your browser doesn't support javascript.
loading
Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders.
Blanco, Sandra; Dietmann, Sabine; Flores, Joana V; Hussain, Shobbir; Kutter, Claudia; Humphreys, Peter; Lukk, Margus; Lombard, Patrick; Treps, Lucas; Popis, Martyna; Kellner, Stefanie; Hölter, Sabine M; Garrett, Lillian; Wurst, Wolfgang; Becker, Lore; Klopstock, Thomas; Fuchs, Helmut; Gailus-Durner, Valerie; Hrabe de Angelis, Martin; Káradóttir, Ragnhildur T; Helm, Mark; Ule, Jernej; Gleeson, Joseph G; Odom, Duncan T; Frye, Michaela.
Afiliação
  • Blanco S; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Dietmann S; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Flores JV; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Hussain S; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Kutter C; Li Ka Shing Centre, CR-UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Humphreys P; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Lukk M; Li Ka Shing Centre, CR-UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Lombard P; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Treps L; CNRS, UMR8104, Paris, France.
  • Popis M; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Kellner S; Johannes Gutenberg University Mainz, Institute for Pharmacy and Biochemistry, Mainz, Germany.
  • Hölter SM; German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
  • Garrett L; German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
  • Wurst W; German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany German Center for Vertigo and Balance Disorders, Munich, Germany.
  • Becker L; German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany Institute for Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
  • Klopstock T; German Center for Vertigo and Balance Disorders, Munich, Germany Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany.
  • Fuchs H; German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany Institute for Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
  • Gailus-Durner V; German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany Institute for Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
  • Hrabe de Angelis M; German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany Institute for Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
  • Káradóttir RT; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Helm M; Johannes Gutenberg University Mainz, Institute for Pharmacy and Biochemistry, Mainz, Germany.
  • Ule J; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
  • Gleeson JG; Laboratory of Pediatric Brain Diseases, Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.
  • Odom DT; Li Ka Shing Centre, CR-UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Frye M; Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK Michaela.Frye@cancer.org.uk mf364@cam.ac.uk.
EMBO J ; 33(18): 2020-39, 2014 Sep 17.
Article em En | MEDLINE | ID: mdl-25063673
ABSTRACT
Mutations in the cytosine-5 RNA methyltransferase NSun2 cause microcephaly and other neurological abnormalities in mice and human. How post-transcriptional methylation contributes to the human disease is currently unknown. By comparing gene expression data with global cytosine-5 RNA methylomes in patient fibroblasts and NSun2-deficient mice, we find that loss of cytosine-5 RNA methylation increases the angiogenin-mediated endonucleolytic cleavage of transfer RNAs (tRNA) leading to an accumulation of 5' tRNA-derived small RNA fragments. Accumulation of 5' tRNA fragments in the absence of NSun2 reduces protein translation rates and activates stress pathways leading to reduced cell size and increased apoptosis of cortical, hippocampal and striatal neurons. Mechanistically, we demonstrate that angiogenin binds with higher affinity to tRNAs lacking site-specific NSun2-mediated methylation and that the presence of 5' tRNA fragments is sufficient and required to trigger cellular stress responses. Furthermore, the enhanced sensitivity of NSun2-deficient brains to oxidative stress can be rescued through inhibition of angiogenin during embryogenesis. In conclusion, failure in NSun2-mediated tRNA methylation contributes to human diseases via stress-induced RNA cleavage.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA de Transferência / Regulação da Expressão Gênica / Metiltransferases / Doenças do Sistema Nervoso Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA de Transferência / Regulação da Expressão Gênica / Metiltransferases / Doenças do Sistema Nervoso Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article